← Leaderboards
Benjamin Djulbegovic
University Of South Florida
$4,463,195
Attributed
$4,463,195
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $400K · FY2005–21$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
AHRQ$2,270,465 · 1
NIH$2,192,730 · 5
By mechanism
R01$4,463,195 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of South Florida
Same institution · by research overlap
- Jeffrey P Krischer$693,386,575
- William S. Dalton$20,173,582
- John C Ruckdeschel$5,148,335
- Daniel M Sullivan$9,547,844
- Tamara A Baker$1,320,133
Others in their field
Top investigators on “Publications”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$594,579,944
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,646,245
- David R. Weir · University Of Michigan At Ann Arbor$413,621,536
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Wafaa M. El-Sadr · Columbia University Health Sciences$334,704,182
Research focus
PublicationsClinical TrialsClinical ResearchHealth Science Research Analysis /EvaluationBasePolicy MakerDesignMalignant NeoplasmsHealthcareNational Cancer InstituteResearch PersonnelCancer TherapyFundingFunding AgencyRandomized Controlled TrialsEthicsBiasPublishingData Collection Methodology /EvaluationClassificationChoices And ControlCancer PreventionAffectData Collection
Grant awards (17)
PA-20-070 "Development of evidence-based decision support for the management of COVID19"$399,999
R01 · FY2021 · HS · contact PI
Evaluation of the Group Decision-Making Process of Clinical Guideline Panels$358,118
R01 · FY2020 · HS · contact PI
Evaluation of the Group Decision-Making Process of Clinical Guideline Panels$362,977
R01 · FY2019 · HS · contact PI
Evaluation of the Group Decision-Making Process of Clinical Guideline Panels$373,816
R01 · FY2018 · HS · contact PI
Evaluation of the Group Decision-Making Process of Clinical Guideline Panels$320,921
R01 · FY2017 · HS · contact PI
Evaluation of the Group Decision-Making Process of Clinical Guideline Panels$63,580
R01 · FY2017 · HS · contact PI
Evaluation of the Group Decision-Making Process of Clinical Guideline Panels$391,054
R01 · FY2016 · HS · contact PI
Treatment Success and Ethical Principle of Equipoise$307,464
R01 · FY2010 · CA · contact PI
Treatment Success and Ethical Principle of Equipoise$323,719
R01 · FY2009 · CA · contact PI
Quality of Research on Treatment Harms in Cancer$282,359
R01 · FY2008 · CA · contact PI
Quality of Research on Treatment Harms in Cancer$256,725
R01 · FY2007 · CA · contact PI
Evaluation of the Quality of Clinical Trials$219,713
R01 · FY2006 · NS · contact PI
Evaluation of the Quality of Clinical Trials$225,000
R01 · FY2005 · NS
Equipoise and the research integrity of clinical trials$145,000
R01 · FY2003 · NS
Blood vs. bone marrow stem transplant$142,750
R01 · FY2003 · HL
Equipoise and the research integrity of clinical trials$145,000
R01 · FY2002 · NS
Blood vs. bone marrow stem transplant$145,000
R01 · FY2002 · HL